Poole Hospital is an acute general hospital in Poole, Dorset, England. Built in 1907, it has expanded from a basic 14-bed facility into a 789-bed hospital. It is the trauma centre for east Dorset and provides specialist services such as cancer treatment for the entire county.

There are 789 beds in Poole Hospital.

During the past decade, Poole Hospital conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 7 clinical trials were completed, i.e. on average, 23.3% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 3 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Poole Hospital" #1 sponsor was "Royal Marsden NHS Foundation Trust" with 5 trials, followed by "Poole Hospital NHS Foundation Trust" with 4 trials sponsored, "University College, London" with 3 trials sponsored, "Amgen" with 2 trials sponsored and "Bayer" with 2 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Poole Hospital" #1 collaborator was "Cancer Research UK" with 4 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator, "Bayer" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator and "NHS Greater Glasgow and Clyde" with 2 trials as a collaborator. Other collaborators include 57 different institutions and companies that were collaborators in the rest 65 trials.

According to Clinical.Site data, the most researched conditions in "Poole Hospital" are "Atrial Fibrillation" (5 trials), "Breast Cancer" (3 trials), "Colorectal Cancer" (3 trials), "Adenocarcinoma" (2 trials) and "Adenocarcinoma, Mucinous" (2 trials). Many other conditions were trialed in "Poole Hospital" in a lesser frequency.

Most popular intervention types in "Poole Hospital" are "Drug" (32 trials), "Other" (7 trials), "Procedure" (7 trials), "Device" (5 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Apixaban" (2 trials), "Apremilast 20mg" (2 trials), "Apremilast 30mg" (2 trials) and "Docetaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Poole Hospital" are 48 trials for "All" genders, 8 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Poole Hospital". 1 are not yet recruiting, 11 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Poole Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Poole Hospital, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".